| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Concussion | 63 | 2026 | 231 | 13.250 |
Why?
|
| Brain Injuries | 89 | 2025 | 693 | 11.220 |
Why?
|
| Brain Injuries, Traumatic | 37 | 2025 | 290 | 7.980 |
Why?
|
| White Matter | 26 | 2024 | 205 | 6.600 |
Why?
|
| Military Personnel | 29 | 2026 | 208 | 6.260 |
Why?
|
| Brain | 69 | 2026 | 3034 | 5.450 |
Why?
|
| Neuroimaging | 27 | 2025 | 362 | 5.290 |
Why?
|
| Magnetic Resonance Imaging | 78 | 2026 | 3714 | 4.700 |
Why?
|
| Veterans | 41 | 2026 | 1742 | 4.330 |
Why?
|
| Diffusion Tensor Imaging | 36 | 2024 | 243 | 3.960 |
Why?
|
| Stress Disorders, Post-Traumatic | 28 | 2026 | 650 | 3.870 |
Why?
|
| Blast Injuries | 11 | 2024 | 58 | 2.640 |
Why?
|
| Low-Level Light Therapy | 4 | 2025 | 18 | 2.290 |
Why?
|
| Neuropsychological Tests | 50 | 2025 | 952 | 2.120 |
Why?
|
| Cognition Disorders | 25 | 2025 | 542 | 2.020 |
Why?
|
| Intimate Partner Violence | 6 | 2026 | 29 | 1.880 |
Why?
|
| Athletic Injuries | 10 | 2025 | 64 | 1.750 |
Why?
|
| Nerve Fibers, Myelinated | 12 | 2014 | 79 | 1.490 |
Why?
|
| Trauma Severity Indices | 12 | 2024 | 86 | 1.460 |
Why?
|
| Cerebral Cortex | 9 | 2020 | 440 | 1.400 |
Why?
|
| Humans | 208 | 2026 | 127099 | 1.360 |
Why?
|
| Adult | 87 | 2026 | 30435 | 1.330 |
Why?
|
| Post-Concussion Syndrome | 11 | 2024 | 50 | 1.320 |
Why?
|
| Phantoms, Imaging | 4 | 2024 | 131 | 1.320 |
Why?
|
| Mental Disorders | 12 | 2025 | 862 | 1.310 |
Why?
|
| Image Processing, Computer-Assisted | 23 | 2024 | 589 | 1.310 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 12 | 2024 | 148 | 1.270 |
Why?
|
| Memory Disorders | 8 | 2015 | 207 | 1.240 |
Why?
|
| Acceleration | 3 | 2025 | 24 | 1.230 |
Why?
|
| Male | 132 | 2026 | 62658 | 1.180 |
Why?
|
| Cognition | 16 | 2026 | 785 | 1.170 |
Why?
|
| Nerve Net | 3 | 2024 | 244 | 1.160 |
Why?
|
| Adolescent | 92 | 2025 | 20082 | 1.150 |
Why?
|
| Female | 132 | 2026 | 68483 | 1.130 |
Why?
|
| Anisotropy | 21 | 2023 | 116 | 1.110 |
Why?
|
| Temporal Lobe | 5 | 2016 | 115 | 0.950 |
Why?
|
| Corpus Callosum | 8 | 2021 | 103 | 0.950 |
Why?
|
| Neural Pathways | 8 | 2018 | 260 | 0.950 |
Why?
|
| Middle Aged | 55 | 2026 | 27801 | 0.910 |
Why?
|
| Firefighters | 1 | 2025 | 35 | 0.870 |
Why?
|
| Young Adult | 44 | 2026 | 9694 | 0.860 |
Why?
|
| Neurologic Examination | 8 | 2018 | 194 | 0.850 |
Why?
|
| Soccer | 2 | 2024 | 8 | 0.830 |
Why?
|
| Cerebellum | 3 | 2025 | 414 | 0.820 |
Why?
|
| Alcoholism | 2 | 2022 | 242 | 0.790 |
Why?
|
| Musculoskeletal System | 2 | 2021 | 18 | 0.760 |
Why?
|
| Child | 74 | 2025 | 25228 | 0.750 |
Why?
|
| Memory, Short-Term | 9 | 2022 | 140 | 0.750 |
Why?
|
| Craniocerebral Trauma | 4 | 2026 | 138 | 0.750 |
Why?
|
| Memory | 9 | 2024 | 346 | 0.730 |
Why?
|
| Longitudinal Studies | 21 | 2025 | 1431 | 0.730 |
Why?
|
| Biomedical Research | 2 | 2025 | 533 | 0.720 |
Why?
|
| Research Design | 6 | 2018 | 692 | 0.720 |
Why?
|
| Brain Mapping | 12 | 2024 | 368 | 0.710 |
Why?
|
| Prefrontal Cortex | 5 | 2022 | 208 | 0.700 |
Why?
|
| Socialization | 1 | 2020 | 15 | 0.670 |
Why?
|
| Behavior | 2 | 2012 | 69 | 0.670 |
Why?
|
| Executive Function | 5 | 2018 | 118 | 0.640 |
Why?
|
| Chronic Traumatic Encephalopathy | 2 | 2019 | 6 | 0.640 |
Why?
|
| Atrophy | 10 | 2023 | 238 | 0.630 |
Why?
|
| Basal Ganglia | 2 | 2012 | 58 | 0.610 |
Why?
|
| Image Interpretation, Computer-Assisted | 7 | 2024 | 230 | 0.610 |
Why?
|
| Control Groups | 1 | 2018 | 11 | 0.590 |
Why?
|
| Cohort Studies | 15 | 2024 | 4972 | 0.570 |
Why?
|
| Verbal Learning | 6 | 2024 | 67 | 0.560 |
Why?
|
| Recovery of Function | 9 | 2020 | 439 | 0.550 |
Why?
|
| Iraq War, 2003-2011 | 12 | 2022 | 126 | 0.510 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 109 | 0.500 |
Why?
|
| Unconsciousness | 1 | 2016 | 17 | 0.490 |
Why?
|
| Boxing | 1 | 2015 | 4 | 0.490 |
Why?
|
| Glasgow Coma Scale | 13 | 2018 | 197 | 0.480 |
Why?
|
| Afghan Campaign 2001- | 11 | 2022 | 118 | 0.470 |
Why?
|
| Cross-Sectional Studies | 18 | 2026 | 3680 | 0.470 |
Why?
|
| Prospective Studies | 18 | 2026 | 6242 | 0.450 |
Why?
|
| United States | 22 | 2026 | 11386 | 0.440 |
Why?
|
| Emotions | 3 | 2013 | 357 | 0.420 |
Why?
|
| Postural Balance | 4 | 2024 | 129 | 0.420 |
Why?
|
| Mental Processes | 1 | 2013 | 37 | 0.410 |
Why?
|
| Sex Offenses | 2 | 2025 | 52 | 0.410 |
Why?
|
| Cerebrum | 1 | 2013 | 33 | 0.410 |
Why?
|
| Brain Injury, Chronic | 3 | 2018 | 17 | 0.400 |
Why?
|
| Cognitive Dysfunction | 3 | 2022 | 285 | 0.400 |
Why?
|
| Social Behavior | 5 | 2014 | 217 | 0.400 |
Why?
|
| Research Report | 1 | 2013 | 70 | 0.400 |
Why?
|
| Pilot Projects | 7 | 2025 | 1399 | 0.400 |
Why?
|
| Gray Matter | 3 | 2025 | 44 | 0.380 |
Why?
|
| Dominance, Cerebral | 3 | 2009 | 49 | 0.380 |
Why?
|
| Gyrus Cinguli | 2 | 2013 | 125 | 0.380 |
Why?
|
| Affective Symptoms | 2 | 2013 | 56 | 0.370 |
Why?
|
| Biomarkers | 8 | 2026 | 3233 | 0.370 |
Why?
|
| Reproducibility of Results | 11 | 2024 | 2886 | 0.360 |
Why?
|
| Child Development | 2 | 2018 | 264 | 0.360 |
Why?
|
| Frontal Lobe | 3 | 2010 | 115 | 0.360 |
Why?
|
| Perforant Pathway | 1 | 2011 | 10 | 0.350 |
Why?
|
| Amygdala | 2 | 2013 | 79 | 0.350 |
Why?
|
| Hippocampus | 4 | 2021 | 778 | 0.350 |
Why?
|
| Alzheimer Disease | 4 | 2022 | 835 | 0.350 |
Why?
|
| Organ Size | 5 | 2024 | 426 | 0.340 |
Why?
|
| Aging | 3 | 2024 | 1198 | 0.330 |
Why?
|
| Angelman Syndrome | 1 | 2010 | 66 | 0.320 |
Why?
|
| Developmental Disabilities | 2 | 2013 | 718 | 0.320 |
Why?
|
| Hypothermia, Induced | 3 | 2021 | 164 | 0.320 |
Why?
|
| Nerve Fibers | 1 | 2010 | 67 | 0.310 |
Why?
|
| Brain Neoplasms | 3 | 2023 | 1235 | 0.310 |
Why?
|
| Case-Control Studies | 11 | 2022 | 3322 | 0.300 |
Why?
|
| Aged | 21 | 2025 | 20431 | 0.300 |
Why?
|
| Age Factors | 9 | 2024 | 2799 | 0.290 |
Why?
|
| Athletes | 3 | 2024 | 70 | 0.290 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 3 | 2023 | 45 | 0.270 |
Why?
|
| Hypothermia | 2 | 2021 | 63 | 0.270 |
Why?
|
| Tomography, Emission-Computed | 2 | 2006 | 36 | 0.270 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2020 | 220 | 0.260 |
Why?
|
| Head Injuries, Closed | 1 | 2007 | 44 | 0.260 |
Why?
|
| Reperfusion Injury | 2 | 2021 | 108 | 0.250 |
Why?
|
| Adaptation, Psychological | 5 | 2024 | 428 | 0.250 |
Why?
|
| Functional Laterality | 6 | 2016 | 172 | 0.250 |
Why?
|
| Amnesia, Retrograde | 1 | 2006 | 3 | 0.250 |
Why?
|
| Magnetoencephalography | 3 | 2023 | 41 | 0.250 |
Why?
|
| Analysis of Variance | 7 | 2014 | 946 | 0.250 |
Why?
|
| Medical Audit | 1 | 2006 | 96 | 0.240 |
Why?
|
| Chronic Pain | 2 | 2018 | 154 | 0.240 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2018 | 384 | 0.240 |
Why?
|
| Pediatrics | 2 | 2012 | 1203 | 0.230 |
Why?
|
| Sports | 1 | 2025 | 61 | 0.220 |
Why?
|
| Arachidonic Acid | 1 | 2024 | 54 | 0.220 |
Why?
|
| Entorhinal Cortex | 1 | 2024 | 27 | 0.220 |
Why?
|
| Apolipoprotein E4 | 1 | 2024 | 47 | 0.220 |
Why?
|
| Writing | 1 | 2025 | 60 | 0.220 |
Why?
|
| MicroRNAs | 2 | 2022 | 871 | 0.220 |
Why?
|
| tau Proteins | 3 | 2026 | 236 | 0.220 |
Why?
|
| Docosahexaenoic Acids | 1 | 2024 | 65 | 0.210 |
Why?
|
| Algorithms | 3 | 2024 | 1633 | 0.210 |
Why?
|
| Problem Solving | 3 | 2010 | 65 | 0.210 |
Why?
|
| Statistics as Topic | 4 | 2016 | 238 | 0.210 |
Why?
|
| Rest | 2 | 2024 | 62 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 1273 | 0.210 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2016 | 173 | 0.210 |
Why?
|
| Chronic Disease | 4 | 2019 | 1199 | 0.200 |
Why?
|
| Axons | 1 | 2006 | 373 | 0.200 |
Why?
|
| Multiple Trauma | 1 | 2024 | 62 | 0.200 |
Why?
|
| Glasgow Outcome Scale | 4 | 2013 | 47 | 0.200 |
Why?
|
| Conduct Disorder | 1 | 2023 | 32 | 0.200 |
Why?
|
| Prognosis | 6 | 2022 | 4799 | 0.200 |
Why?
|
| Severity of Illness Index | 9 | 2022 | 2991 | 0.190 |
Why?
|
| Parietal Lobe | 2 | 2016 | 43 | 0.190 |
Why?
|
| Survivorship | 1 | 2022 | 46 | 0.180 |
Why?
|
| Acute Disease | 4 | 2018 | 1141 | 0.180 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2021 | 12 | 0.180 |
Why?
|
| Football | 1 | 2021 | 36 | 0.180 |
Why?
|
| Follow-Up Studies | 8 | 2021 | 5148 | 0.170 |
Why?
|
| Frontotemporal Dementia | 1 | 2022 | 67 | 0.170 |
Why?
|
| Proton Therapy | 1 | 2022 | 152 | 0.170 |
Why?
|
| Theory of Mind | 2 | 2011 | 28 | 0.170 |
Why?
|
| Neuropsychology | 1 | 2021 | 24 | 0.170 |
Why?
|
| Musculoskeletal Diseases | 3 | 2021 | 53 | 0.170 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 231 | 0.170 |
Why?
|
| Socioeconomic Factors | 4 | 2015 | 881 | 0.170 |
Why?
|
| Sex Factors | 4 | 2025 | 1311 | 0.160 |
Why?
|
| Treatment Outcome | 10 | 2015 | 12567 | 0.160 |
Why?
|
| Artifacts | 1 | 2021 | 103 | 0.160 |
Why?
|
| Exosomes | 1 | 2020 | 58 | 0.160 |
Why?
|
| Psychiatric Status Rating Scales | 7 | 2018 | 823 | 0.160 |
Why?
|
| Radiography | 2 | 2012 | 753 | 0.160 |
Why?
|
| Oxygen | 5 | 2018 | 540 | 0.150 |
Why?
|
| Dementia | 2 | 2022 | 416 | 0.150 |
Why?
|
| Depression | 5 | 2024 | 1294 | 0.150 |
Why?
|
| Exercise | 1 | 2025 | 844 | 0.150 |
Why?
|
| Youth Sports | 1 | 2018 | 6 | 0.150 |
Why?
|
| Health Communication | 1 | 2019 | 30 | 0.150 |
Why?
|
| Common Data Elements | 1 | 2018 | 6 | 0.150 |
Why?
|
| Brain Contusion | 1 | 2018 | 2 | 0.150 |
Why?
|
| Time Factors | 9 | 2015 | 6142 | 0.140 |
Why?
|
| Memory, Episodic | 2 | 2016 | 27 | 0.140 |
Why?
|
| Sensation Disorders | 1 | 2018 | 24 | 0.140 |
Why?
|
| Adolescent Development | 1 | 2018 | 32 | 0.140 |
Why?
|
| Fractures, Bone | 1 | 2020 | 193 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2016 | 2048 | 0.140 |
Why?
|
| Caudate Nucleus | 2 | 2015 | 36 | 0.130 |
Why?
|
| Risk Factors | 10 | 2025 | 10610 | 0.130 |
Why?
|
| Reference Values | 3 | 2008 | 669 | 0.130 |
Why?
|
| Anxiety Disorders | 2 | 2015 | 696 | 0.130 |
Why?
|
| Ventral Striatum | 1 | 2016 | 27 | 0.130 |
Why?
|
| Space Perception | 1 | 2016 | 49 | 0.120 |
Why?
|
| Survivors | 3 | 2023 | 347 | 0.120 |
Why?
|
| Patient Outcome Assessment | 1 | 2016 | 92 | 0.120 |
Why?
|
| Supervised Machine Learning | 1 | 2016 | 10 | 0.120 |
Why?
|
| Electroencephalography | 1 | 2020 | 822 | 0.120 |
Why?
|
| Databases, Factual | 2 | 2024 | 1194 | 0.120 |
Why?
|
| Quality of Life | 4 | 2026 | 2029 | 0.120 |
Why?
|
| Child, Preschool | 12 | 2022 | 14423 | 0.120 |
Why?
|
| Activities of Daily Living | 3 | 2024 | 402 | 0.110 |
Why?
|
| War Exposure | 1 | 2015 | 8 | 0.110 |
Why?
|
| Perception | 1 | 2016 | 228 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2017 | 358 | 0.110 |
Why?
|
| Sports Medicine | 1 | 2015 | 29 | 0.110 |
Why?
|
| Proof of Concept Study | 2 | 2025 | 33 | 0.110 |
Why?
|
| Connectome | 1 | 2016 | 97 | 0.110 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2015 | 84 | 0.110 |
Why?
|
| Communication Disorders | 1 | 2014 | 10 | 0.110 |
Why?
|
| Predictive Value of Tests | 5 | 2015 | 2233 | 0.110 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2014 | 2 | 0.110 |
Why?
|
| Speech Perception | 1 | 2014 | 52 | 0.110 |
Why?
|
| Psychological Tests | 2 | 2013 | 93 | 0.110 |
Why?
|
| Personality | 1 | 2015 | 112 | 0.110 |
Why?
|
| Injury Severity Score | 3 | 2014 | 222 | 0.110 |
Why?
|
| Intelligence Tests | 3 | 2022 | 59 | 0.100 |
Why?
|
| Social Class | 3 | 2022 | 206 | 0.100 |
Why?
|
| Functional Neuroimaging | 1 | 2013 | 35 | 0.100 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2026 | 101 | 0.100 |
Why?
|
| User-Computer Interface | 2 | 2013 | 155 | 0.100 |
Why?
|
| Comorbidity | 4 | 2023 | 1562 | 0.100 |
Why?
|
| Explosions | 2 | 2024 | 6 | 0.100 |
Why?
|
| Social Behavior Disorders | 1 | 2013 | 12 | 0.100 |
Why?
|
| Accidents, Traffic | 2 | 2010 | 104 | 0.100 |
Why?
|
| Observer Variation | 2 | 2010 | 308 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 2 | 2016 | 460 | 0.100 |
Why?
|
| Linear Models | 3 | 2009 | 687 | 0.100 |
Why?
|
| Disability Evaluation | 2 | 2010 | 189 | 0.100 |
Why?
|
| Personality Disorders | 1 | 2015 | 169 | 0.100 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2012 | 10 | 0.100 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 148 | 0.090 |
Why?
|
| Sexual Behavior | 1 | 2014 | 245 | 0.090 |
Why?
|
| Intention | 1 | 2013 | 100 | 0.090 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 223 | 0.090 |
Why?
|
| Affect | 1 | 2013 | 167 | 0.090 |
Why?
|
| Body Temperature | 1 | 2012 | 123 | 0.090 |
Why?
|
| Cognitive Reserve | 1 | 2011 | 5 | 0.090 |
Why?
|
| Diffusion | 2 | 2010 | 55 | 0.090 |
Why?
|
| Urban Population | 1 | 2014 | 275 | 0.090 |
Why?
|
| Radionuclide Imaging | 1 | 2012 | 123 | 0.090 |
Why?
|
| Resilience, Psychological | 1 | 2013 | 77 | 0.090 |
Why?
|
| Task Performance and Analysis | 1 | 2011 | 80 | 0.090 |
Why?
|
| Brain Edema | 2 | 2009 | 62 | 0.090 |
Why?
|
| Fornix, Brain | 1 | 2010 | 20 | 0.080 |
Why?
|
| Thalamus | 2 | 2008 | 80 | 0.080 |
Why?
|
| Mood Disorders | 3 | 2018 | 124 | 0.080 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 669 | 0.080 |
Why?
|
| Time | 2 | 2010 | 94 | 0.080 |
Why?
|
| Surveys and Questionnaires | 4 | 2018 | 3933 | 0.080 |
Why?
|
| Matched-Pair Analysis | 2 | 2008 | 28 | 0.080 |
Why?
|
| Reaction Time | 2 | 2024 | 156 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 2071 | 0.080 |
Why?
|
| Facial Expression | 2 | 2013 | 27 | 0.080 |
Why?
|
| Warfare | 1 | 2010 | 33 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2010 | 143 | 0.080 |
Why?
|
| Wounds and Injuries | 1 | 2014 | 381 | 0.080 |
Why?
|
| Retrospective Studies | 6 | 2025 | 17065 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 2036 | 0.080 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2010 | 132 | 0.080 |
Why?
|
| Automation | 1 | 2010 | 65 | 0.080 |
Why?
|
| Multivariate Analysis | 2 | 2022 | 1387 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 821 | 0.080 |
Why?
|
| Neuronal Plasticity | 1 | 2012 | 283 | 0.080 |
Why?
|
| Motivation | 1 | 2011 | 326 | 0.070 |
Why?
|
| Mesencephalon | 1 | 2008 | 38 | 0.070 |
Why?
|
| Verbal Behavior | 3 | 2016 | 48 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 1178 | 0.070 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2025 | 692 | 0.070 |
Why?
|
| Attention | 3 | 2016 | 192 | 0.070 |
Why?
|
| Mental Recall | 2 | 2021 | 138 | 0.070 |
Why?
|
| Prevalence | 4 | 2016 | 2612 | 0.070 |
Why?
|
| Canada | 3 | 2013 | 315 | 0.060 |
Why?
|
| Rehabilitation Centers | 1 | 2006 | 27 | 0.060 |
Why?
|
| Pain Measurement | 2 | 2018 | 350 | 0.060 |
Why?
|
| Decision Making | 1 | 2011 | 666 | 0.060 |
Why?
|
| Neurofilament Proteins | 1 | 2026 | 29 | 0.060 |
Why?
|
| Cerebral Ventricles | 1 | 2006 | 80 | 0.060 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2026 | 63 | 0.060 |
Why?
|
| Interpersonal Relations | 2 | 2021 | 218 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2006 | 128 | 0.060 |
Why?
|
| Head | 1 | 2025 | 109 | 0.060 |
Why?
|
| Paraparesis, Spastic | 1 | 2004 | 4 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2005 | 267 | 0.050 |
Why?
|
| Deep Brain Stimulation | 1 | 2009 | 402 | 0.050 |
Why?
|
| Aging, Premature | 1 | 2024 | 30 | 0.050 |
Why?
|
| Hand Strength | 1 | 2024 | 56 | 0.050 |
Why?
|
| Visual Perception | 1 | 2005 | 124 | 0.050 |
Why?
|
| Central Nervous System Depressants | 1 | 2004 | 21 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2025 | 424 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 1 | 2004 | 149 | 0.050 |
Why?
|
| Self Report | 2 | 2018 | 538 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 6695 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2017 | 765 | 0.050 |
Why?
|
| Ethanol | 1 | 2004 | 158 | 0.050 |
Why?
|
| Parkinson Disease | 1 | 2009 | 701 | 0.050 |
Why?
|
| Psychometrics | 1 | 2006 | 655 | 0.050 |
Why?
|
| Protons | 1 | 2022 | 99 | 0.050 |
Why?
|
| Trail Making Test | 1 | 2021 | 6 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2024 | 406 | 0.050 |
Why?
|
| Intelligence | 2 | 2015 | 91 | 0.040 |
Why?
|
| Hematoma, Subdural | 1 | 2021 | 26 | 0.040 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2021 | 29 | 0.040 |
Why?
|
| International Classification of Diseases | 1 | 2022 | 94 | 0.040 |
Why?
|
| Disease Progression | 2 | 2018 | 2118 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2022 | 287 | 0.040 |
Why?
|
| Length of Stay | 1 | 2006 | 1378 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 276 | 0.040 |
Why?
|
| Nervous System Malformations | 1 | 2021 | 119 | 0.040 |
Why?
|
| Polysomnography | 1 | 2020 | 147 | 0.040 |
Why?
|
| Newspapers as Topic | 1 | 2019 | 6 | 0.040 |
Why?
|
| Preliminary Data | 1 | 2018 | 8 | 0.040 |
Why?
|
| United States Department of Defense | 1 | 2018 | 9 | 0.040 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2018 | 12 | 0.040 |
Why?
|
| Learning | 1 | 2021 | 358 | 0.030 |
Why?
|
| Psychotherapy | 1 | 2021 | 241 | 0.030 |
Why?
|
| Language | 2 | 2011 | 205 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2018 | 233 | 0.030 |
Why?
|
| Environment | 1 | 2018 | 150 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2009 | 3074 | 0.030 |
Why?
|
| Psychomotor Performance | 2 | 2010 | 173 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2018 | 225 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2004 | 1570 | 0.030 |
Why?
|
| Animals | 3 | 2015 | 33157 | 0.030 |
Why?
|
| Hospitals, Veterans | 1 | 2018 | 341 | 0.030 |
Why?
|
| Globus Pallidus | 1 | 2016 | 68 | 0.030 |
Why?
|
| Sleep Wake Disorders | 1 | 2018 | 189 | 0.030 |
Why?
|
| Life Style | 1 | 2018 | 432 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2016 | 193 | 0.030 |
Why?
|
| Narration | 1 | 2014 | 33 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 1536 | 0.030 |
Why?
|
| Vocalization, Animal | 1 | 2014 | 22 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2018 | 756 | 0.030 |
Why?
|
| Anxiety | 1 | 2021 | 964 | 0.030 |
Why?
|
| Violence | 1 | 2014 | 128 | 0.020 |
Why?
|
| Alkaloids | 1 | 2013 | 36 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 429 | 0.020 |
Why?
|
| Suction | 1 | 2012 | 49 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2011 | 3588 | 0.020 |
Why?
|
| Inpatients | 1 | 2016 | 540 | 0.020 |
Why?
|
| Family Health | 1 | 2013 | 248 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 272 | 0.020 |
Why?
|
| Craniotomy | 1 | 2012 | 100 | 0.020 |
Why?
|
| Causality | 1 | 2011 | 88 | 0.020 |
Why?
|
| Intracranial Pressure | 1 | 2012 | 200 | 0.020 |
Why?
|
| Computer Graphics | 1 | 2010 | 37 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2011 | 316 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 423 | 0.020 |
Why?
|
| Bone Diseases | 1 | 2011 | 42 | 0.020 |
Why?
|
| Social Perception | 1 | 2011 | 53 | 0.020 |
Why?
|
| Pyramidal Tracts | 1 | 2010 | 36 | 0.020 |
Why?
|
| Putamen | 1 | 2010 | 21 | 0.020 |
Why?
|
| Internal Capsule | 1 | 2010 | 50 | 0.020 |
Why?
|
| Language Disorders | 1 | 2009 | 23 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2010 | 161 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 734 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2009 | 186 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 2009 | 168 | 0.020 |
Why?
|
| Family | 1 | 2012 | 580 | 0.020 |
Why?
|
| Brain Stem | 1 | 2008 | 108 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 1206 | 0.020 |
Why?
|
| Pons | 1 | 2007 | 33 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 560 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2012 | 1309 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2009 | 1216 | 0.010 |
Why?
|
| Infant | 2 | 2011 | 12784 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 4510 | 0.010 |
Why?
|
| Software | 1 | 2010 | 710 | 0.010 |
Why?
|
| Michigan | 1 | 2004 | 46 | 0.010 |
Why?
|
| Presenilin-1 | 1 | 2004 | 57 | 0.010 |
Why?
|
| Codon | 1 | 2004 | 95 | 0.010 |
Why?
|
| Texas | 1 | 2013 | 3563 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 398 | 0.010 |
Why?
|
| Age of Onset | 1 | 2004 | 609 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 17680 | 0.010 |
Why?
|